Advertisement

Association between Helicobacter pylori Infection and Pancreatic Cancer. A Cumulative Meta-Analysis.

08:12 EDT 21st May 2013 | BioPortfolio

Summary of "Association between Helicobacter pylori Infection and Pancreatic Cancer. A Cumulative Meta-Analysis."

Infection with Helicobacter pylori (H. pylori) has been implicated in the etiopathogenesis of various malignant conditions. Notwithstanding, its etiological association with pancreatic cancer remains inconclusive. Studies focusing on the relationship between H. pylori infection and pancreatic cancer risk have yielded conflicting results.

Affiliation

Department of Internal Medicine, University of Connecticut Medical Center. Farmington, CT, USA. wbaker@uchc.edu.

Journal Details

This article was published in the following journal.

Name: JOP : Journal of the pancreas
ISSN: 1590-8577
Pages: 26-31

Links

Medical and Biotech [MESH] Definitions

Helicobacter Infections

Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease.

Helicobacter Pylori

A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405).

Helicobacter Heilmannii

A species of gram-negative, spiral-shaped bacteria found in the gastric mucosa that is associated with chronic antral gastritis. This bacterium was first discovered in samples removed at endoscopy from patients investigated for HELICOBACTER PYLORI colonization.

Stomach Ulcer

Ulceration of the GASTRIC MUCOSA due to contact with GASTRIC JUICE. It is often associated with HELICOBACTER PYLORI infection or consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).

Peptic Ulcer

Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).

PubMed Articles [ 25959 Associated PubMed Articles listed on BioPortfolio]

Helicobacter pylori in Autoimmune Pancreatitis and Pancreatic Carcinoma.

Background:Helicobacter pylori has been suggested to be involved in pancreatic diseases, namely autoimmune pancreatitis and pancreatic carcinoma. We investigated the presence of conserved sequences of...

Changes in prevalence of helicobacter pylori infection after subtotal gastrectomy.

Background/Aims: There have been few reports comparing pre and postoperative prevalence of Helicobacter pylori infection and gastritis in patients with gastric cancer surgery. Methodology: Seventy pat...

Helicobacter pylori: Bone-marrow-derived cells could cause gastric preneoplasia in chronic Helicobacter pylori infection.

Helicobacter Pylori Persistence in Children: Distinguishing Inadequate Treatment, Resistant Organisms, and Reinfection.

Helicobacter pylori is a worldwide infection that causes chronic gastritis, duodenal ulcers, and malignancy. Transmission of Helicobacter pylori within a family appears to be the predominant mode of c...

Spontaneous clearance of Helicobacter pylori after pylorus-preserving gastrectomy for gastric cancer.

Residual mucosa in the gastric stump after pylorus-preserving gastrectomy (PPG) is considered a risk factor for the development of gastric stump carcinoma (GSC). Duodenogastric reflux (DGR) and Helico...

Clinical Trials [ 4005 Associated Clinical Trials listed on BioPortfolio]

Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori)

The purpose of this study is to compare the effectiveness of three different antibiotic regimens against Helicobacter pylori (H. pylori).

Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection

Helicobacter pylori is a bacteria that infects the lining of the stomach and is associated with ulcers. Helicobacter pylori may also increase the long-term risk of developing certain forms...

Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

The purpose of the study is to confirm the safety and effectiveness of rabeprazole in the treatment of adult patients with Helicobacter pylori (H. pylori) infection in routine clinical pra...

The Role of Cathepsin X in Infection With the Helicobacter Pylori

The immune response to Helicobacter pylori (Hp) importantly determines the pathogenesis of infection as well as the success of antibiotic eradication of the bacteria. The investigators wan...

The Effect of Berry Extract on Helicobacter Pylori Eradication

Helicobacter pylori (HP) is the major risk factors of gastritis, gastric ulcers, duodenal ulcers, mucosa associated lymphoid tissue lymphoma and gastric cancer. Helicobacter pylori are fou...

Search BioPortfolio:
Advertisement
Advertisement

Latest Biotech, Pharma and Healthcare News

Helicobacter pylori Gastritis Approved as Additional Indication in Japan for Helicobacter pylori Eradication by Triple Therapy with Proton Pump Inhibitor

Pasetocin® and Sawacillin®: Approval for Additional Indication for Helicobacter pylori Eradication by Triple Therapy with Proton Pump Inhibitors and either Clarithromycin or Metronidazole

Pasetocin® and Sawacillin®: Joint Application Seeking Approval for Additional Indication for Helicobacter pylori Eradication by Triple Therapy with Proton Pump Inhibitors and either Clarithromycin or Metronidazole

Exalenz Bioscience Awarded GSA Contract

Improve Sensitivity and Specificity for the Most Dangerous Types of H. pylori with Gold Standard Diagnostics’ FDA Cleared EIA

Companies Submit Joint Application Seeking Approval for Additional Indication forHelicobacter pylori Eradication by Concomitant Therapy with Proton Pump Inhibitors, Amoxicillin Hydrate and either Clarithromycin or Metronidazole

Fidelis Diagnostics Partners with Exalenz Bioscience to Add H. pylori Breath Testing Solutions to Its Portfolio of Services


Searches Linking to this Article